Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New home therapy program for Stroke-Affected infants gets spanish adaptation

NCT ID NCT07605988

Knowledge-focused Sponsor: University of Castilla-La Mancha Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study adapts and tests a Spanish version of eTIPS, an early home-based therapy program for infants at risk of unilateral cerebral palsy after perinatal stroke. The program involves parent-delivered activities integrated into daily routines. The study will enroll 20 families to assess feasibility, acceptability, and preliminary effects on infant development.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
eTIPS (parent-delivered home-based therapy program)
What this could lead to
If successful, this could provide a culturally adapted early therapy option for Spanish-speaking families, potentially improving motor development in infants at risk of cerebral palsy.
What could go wrong
This is a very small pilot study (20 participants) focused on feasibility, not effectiveness. The intervention may not show clear benefits or may be difficult for families to implement consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 to 6 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Infants with confirmed unilateral perinatal stroke diagnosis by neuroimaging, identified within first 3 months of life * Age at recruitment ≤3 months postnatal (intervention starts when clinically stable, maximum term-equivalent age) * Written informed consent from parents/legal guardians Exclusion Criteria: * Known progressive neurodegenerative disorder or severe medical comorbidity preventing participation (e.g., ventilation-dependent respiratory failure) * Extensive bilateral intracerebral lesion making lateralized intervention irrelevant * Concurrent participation in another clinical trial with interfering treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Early parent-delivered home-based intervention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pediatric arterial ischemic stroke spastic hemiplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Early parent-delivered home-based intervention Perinatal stroke and risk of unilateral cerebral palsy Spanish cross-cultural adaptation of etips

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.